Methods and biomarker for evaluating cancer metastasis, pharmaceutical composition for inhibiting cancer metastasis, and method for analyzing secretome

貢獻的翻譯標題: 癌症轉移之評估方法及生物標記、抑制癌症轉移之醫藥組成物、及分泌蛋白質體之分析方法

Pao-Chi Liao (Inventor)

研究成果: Patent

摘要

The invention relates to methods and biomarker for evaluating cancer metastasis, pharmaceutical composition for inhibiting cancer metastasis, and method for analyzing secretome. By combining a hollow fiber cartridge (HFC) culture system with quantitative proteomics technology, cancer metastasis-related secrectomes can be found. Furthermore, this is the first time to use PARK7 as a biomarker for judging the process of non-small cell lung cancer.
貢獻的翻譯標題癌症轉移之評估方法及生物標記、抑制癌症轉移之醫藥組成物、及分泌蛋白質體之分析方法
原文English
專利號9194005
出版狀態Published - 1800

指紋 深入研究「癌症轉移之評估方法及生物標記、抑制癌症轉移之醫藥組成物、及分泌蛋白質體之分析方法」主題。共同形成了獨特的指紋。

引用此